While other neurological disorders such as Alzheimer's Disease have an identified prodrome period, only recently have population cohort studies suggested possible evidence for multiple sclerosis (MS) prodrome for both relapse-remitting and primary progressive types. (Makhani and Tremlett, 2021; Tremlett et al., 2021; JMA Wijnands et al., 2019; JM Wijnands et al., 2019) Mild cognitive symptoms, dermatological complaints, and anemia have been identified as possible prodromal presentations. (JMA Wijnands et al., 2019; JM Wijnands et al., 2019) This study aimed to characterize non-routine healthcare utilization before MS diagnosis in a diverse population.